Evidence map›Paper›PMID 34497810›Full record

ArticleFrontiers in cell and developmental biology2021

Prioritizing Susceptible Genes for Thyroid Cancer Based on Gene Interaction Network.

Lin-Kun Zhong, Chang-Lian Xie, Shan Jiang, Xing-Yan Deng, Xiao-Xiong Gan, Jian-Hua Feng, Wen-Song Cai, Chi-Zhuai Liu, Fei Shen, Jian-Hang Miao and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cell and developmental biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 1 country.

Lin-Kun ZhongDepartment of General Surgery, Zhongshan City People's Hospital, Zhongshan, China.
Chang-Lian XieIntensive Care Unit, Zhongshan Hospital of Traditional Chinese Medicine Affiliated to Guangzhou University of Chinese Medicine, Zhongshan, China.
Shan JiangReproductive Medicine Center, Boai Hospital of Zhongshan, Zhongshan, China.
Xing-Yan DengDepartment of Thyrovascular Surgery, Maoming People's Hospital, Maoming, China.
Xiao-Xiong GanDepartment of Thyroid Surgery, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, China.
Jian-Hua FengDepartment of Thyroid Surgery, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, China.
Wen-Song CaiDepartment of Thyroid Surgery, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, China.
Chi-Zhuai LiuDepartment of General Surgery, Zhongshan City People's Hospital, Zhongshan, China.
Fei ShenDepartment of Thyroid Surgery, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, China.
Jian-Hang MiaoDepartment of General Surgery, Zhongshan City People's Hospital, Zhongshan, China.
Bo XuDepartment of Thyroid Surgery, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, China.
Zhongshan People's Hospital · CNGuangzhou Medical University · CNSouth China University of Technology · CNBoai Hospital of Zhongshan · CNGuangzhou First People's Hospital · CNSun Yat-sen University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Thyroid cancer ranks second in the incidence rate of endocrine malignant cancer. Thyroid cancer is usually asymptomatic at the initial stage, which makes patients easily miss the early treatment time. Combining genetic testing with imaging can greatly improve the diagnostic efficiency of thyroid cancer. Researchers have discovered many genes related to thyroid cancer. However, the effects of these genes on thyroid cancer are different. We hypothesize that there is a stronger interaction between the core genes that cause thyroid cancer. Based on this hypothesis, we constructed an interaction network of thyroid cancer-related genes. We traversed the network through random walks, and sorted thyroid cancer-related genes through ADNN which is fusion of Adaboost and deep neural network (DNN). In addition, we discovered more thyroid cancer-related genes by ADNN. In order to verify the accuracy of ADNN, we conducted a fivefold cross-validation. ADNN achieved AUC of 0.85 and AUPR of 0.81, which are more accurate than other methods.

Indexed as

Adaboostdeep neural networkgene interactiongenetic testingthyroid cancer

Identifiers

PMID34497810
PMCPMC8421023
OpenAlexW3196142474

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.